Multidisciplinary Amyloidosis Fellowship

Memorial Sloan Kettering Cancer Center

Haematology & Medical OncologyHaematological malignanciesClinical Fellowship
Destination
USA
New York, United States

Overview

A one-year programme in evaluating and treating systemic amyloidosis, with exposure to BMT, cellular therapy, cardio-oncology and onco-nephrology and a mentored research project.

The programme

Training type
Clinical Fellowship
Duration
1 year, optional 2nd research year
Start
July (flexible)
Positions
1
Accreditation
Not stated on official page
Department
Department of Medicine

Eligibility and visa

Eligibility
Completed IM residency and haematology/oncology fellowship (or equivalent); IM graduates intending to apply for hem/onc may be considered
International applicants
Foreign applicants with equivalent qualifications are eligible to apply (programme page)
Visa support
Not stated on official page
Licence requirement
Not stated on official page

How to apply

Deadline
1 May 2026 (for July 2026-June 2027 cycle)
Application method
Send updated CV and personal statement to Dr Heather Landau; one letter of recommendation sent directly

Funding

Funding
Not stated on official page

Official sources

Similar programmes

More at Memorial Sloan Kettering Cancer Center